{"_id":"QN3anya1xqURyAsjtRhvNEpwh8jKpL675C29h9QERZeo2zAa67BRMf","founded_year":1998,"lastupdate":"2023-10-25T00:00:00.000Z","update_date":"2023-10-25T00:00:00.000Z","lastModified":"Oct 25, 2023","confidence_score":59,"active":1,"confidence_score_reason":"funding stage, product stage, sector, business model, video or image, funding rounds, markets, not claimed","urlname":"illumina","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"description_edited":null,"tag_line_edited":null,"phone":null,"registrar":null,"biverification":"Maor Perlov","recentupdates":[{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:18:32.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:09:48.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:19:06.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:22:13.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:09:48.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 04:55:52.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:21:25.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:09:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2025-02-06 12:36:12.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:10:23.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:09:48.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:22:13.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:35:19.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:10:26.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2023-10-25 09:01:07.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 05:51:03.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-22 06:36:13.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:01:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:10:26.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:15:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:09:56.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:19:06.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:18:34.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:17:06.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:15:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:01:06.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:18:34.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 04:55:52.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:21:16.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:01:07.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:18:34.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:55:29.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:21:16.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:09:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:01:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:01:07.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-10-25 09:01:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2023-10-25 09:01:07.000000","last_name":"Perlov","first_name":"Maor"}],"sectorverify":null,"biverify":{"id":"7JMVZ1cDkplo2zZFEs4WRWhuj0xt9r8fRw5ZIjvtKeO50MH4vxhFbX","fullname":"Maor Perlov"},"biverifydate":"2023-10-25T00:00:00.000Z","crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Maor Perlov","creator_email":"maor.perlov@sncentral.org","createdate":"2023-10-25T00:00:00.000Z","lastupdatedate":"2023-10-25","hide_reason":null,"hide_reason_data":null,"logokey":"$flNnMfmwDLR3ufA0FXfqdrZHp5WYRPgREKod4vTu7hIAWxa6Ircu06.jpeg","name":"Illumina","israeliacquisitions":1,"forbesranking":null,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":[],"alternativenames":null,"country":"United States","inisraelsince":"1/2022","inisraelsincemonth":"1","isisraeli":0,"marketcapital":null,"marketcapitaldate":null,"oneliner":"Biotechnology","website":"http://www.illumina.com/","employees":"11-50","employees_exact":16,"employees_overall":"5,001-10,000","employees_overall_exact":9284,"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/7513","instagram":""},"social":["https://www.linkedin.com/company/7513"],"flattenedsociallinks":"https://www.linkedin.com/company/7513","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Illumina, Inc is a biotechnology firm specializing in the development and marketing of systems for analyzing genetic variation and biological function. Their sequencing systems play a pivotal role in diagnosing genetic diseases, pinpointing cancer mutations, and monitoring treatment outcomes. Additionally, their technologies assist in researching the genetic basis of diseases, drug development, and providing consumers with insights into their genomes.\n\nIn 2022,  Illumina set up an Excellence Center in Israel, emphasizing the advancement of Artificial Intelligence (AI) for genome analysis. Located in Tel Aviv, this center is dedicated to AI-driven interpretation technology, aiding researchers and clinicians. The primary goal is to offer rapid and insightful interpretations, particularly benefiting the diagnosis of rare diseases, notably affecting children under five.","founded":"1/1998","team":[{"name":"Einat Metzer","email":"eMetzer@illumina.com","phone":"","gender":"Female","userid":"aNWQnFj4S4NuMoWCXnWy2feRGBNTvn0CmBGJjoSBSpzXQpdODXiAnS","bounced":true,"claimed":null,"founder":0,"urlname":"einat-metzer","visible":1,"memberid":"WpACnN3hrttdxjiti2DoninmkBZ7hWeOsiRdZ7tE1nifmkPGuds2R3","position":"VP and General Manager, Genetic Disease Testing","last_name":"Metzer","claimtoken":"sHbEZWHRNwdnbvGZLETf5arFcJEjN1ve0eKLgYLr7p5F0Yjd1ZG6v8","first_name":"Einat","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/einatmetzer/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2023-10-25 09:19:19.000000","initials":"EM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"portfolio":[{"name":"Emedgene","hidden":false,"raised":"$6.02M","founded":"2015","fullurl":"/company_page/emedgene","logokey":"$shEWF6CkD1yrMYdlVx5CTnj0hZU62fDGt4WB1b81xR9Ww5MMl5xY45","urlname":"emedgene","employees":"11-50","company_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgI_4scoJDA","description":"AI-based Platform for Automated Genomic Interpretation","fundingstage":"Acquired","businessmodel":"B2B","raisedNumber":6019000,"logourl":"https://storage.googleapis.com/clean-finder-353810/$shEWF6CkD1yrMYdlVx5CTnj0hZU62fDGt4WB1b81xR9Ww5MMl5xY45","style":"","hiddenCompanyTooltip":""}],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":[{"id":"QIUhmaznexUjho10oix3rYQiM1KH6eCIdlaaGaHSdtWXdeHhRYXb6O","city":"Tel Aviv-Yafo","type":["R&D"],"address":"Yigal Alon St 114, Tel Aviv-Yafo, Israel","placeid":"ChIJRQYyv5hLHRURzvAjHQWZvDQ","notactive":0,"openeddate":"2022-01-25","registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"X9q6UoErtubjalW3zXu1Ux5Pe4JGxWmOxyltHKAncmOCPwlZGD7i0d","city":"San Diego","address":"San Diego, CA, USA","country":"United States","placeid":"ChIJSx6SrQ9T2YARed8V_f0hOg0"}]},"headquarter_address":"San Diego, CA, USA","news":[{"id":"ypDTTe7p4nk7KgMUjW3EepHAFG50MhjzReJaHV6beis1nHUO499K8K","date":"Feb 28, 2022","link":"https://www.calcalistech.com/ctechnews/article/ryfdj7ce5","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Artificial Intelligence, Genomics","company":"Illumina","layoffs":"N/A","summary":"Illumina, a leading DNA sequencing company, is establishing an Excellence Center in Israel to advance the development of AI for genome analysis. The center will focus on AI-driven interpretation technology to support researchers and clinicians, aiming to provide faster and more meaningful insights for the diagnosis of rare diseases. The technology developed at the center is expected to significantly reduce analysis time and enable scale in the interpretation of genomic data. This technology has already been adopted by leading medical organizations worldwide, including Baylor Genetics, Boston Children’s Hospital, SickKids Canada, and Mayo Clinic.","partners":"N/A","customers":["Baylor Genetics","Boston Children’s Hospital","SickKids Canada","Mayo Clinic"],"investors":"N/A","confidence":9,"key_topics":["Artificial Intelligence","Genomics","Rare Disease Diagnosis","DNA Sequencing","Data Interpretation"],"date_of_event":"N/A","valuation_amount":"$51 billion","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"RlvDXCoJc9HDcF0L07cWBoGmvXzpJWlAXkyi4eq4aUFYA8T2FwnAwB","news_summary":"DNA sequencing giant Illumina to establish Center of Excellence in Israel | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[],"techcommunityinvolvement":null,"tags":["biotechnology","artificial-intelligence","digital-healthcare"],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"5,001-10,000","fundingtype":"Multinational","parsedName":"Illumina","logourl":"https://storage.googleapis.com/clean-finder-353810/$flNnMfmwDLR3ufA0FXfqdrZHp5WYRPgREKod4vTu7hIAWxa6Ircu06.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$flNnMfmwDLR3ufA0FXfqdrZHp5WYRPgREKod4vTu7hIAWxa6Ircu06.jpeg","teamMembersNumber":1,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}